RETINOPATHY OF PREMATURITY (ROP)
Clinical trials for RETINOPATHY OF PREMATURITY (ROP) explained in plain language.
Never miss a new study
Get alerted when new RETINOPATHY OF PREMATURITY (ROP) trials appear
Sign up with your email to follow new studies for RETINOPATHY OF PREMATURITY (ROP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to save premature babies' eyesight
Disease control Recruiting nowThis early-stage study tests a new medicine called FLQ-101 in 18 premature babies born at 26-27 weeks who are at high risk for retinopathy of prematurity (ROP), an eye disease that can cause blindness. The main goal is to check the drug's safety and how the body processes it. Res…
Matched conditions: RETINOPATHY OF PREMATURITY (ROP)
Phase: PHASE1 • Sponsor: FELIQS INC. • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
Breakthrough drug aims to stop lung disease in tiniest newborns
Prevention Recruiting nowThis study tests an investigational drug called OHB-607 to see if it can prevent bronchopulmonary dysplasia (BPD), a serious chronic lung disease, in extremely premature infants. About 338 babies will be randomly assigned to receive either the drug or standard care. The goal is t…
Matched conditions: RETINOPATHY OF PREMATURITY (ROP)
Phase: PHASE2 • Sponsor: OHB Neonatology Ltd. • Aim: Prevention
Last updated May 04, 2026 16:31 UTC